Erenumab: First-in-Class Approved for Migraine Prevention

Take a closer look at how erenumab, the first CGRP inhibitor to win FDA-approval for migraine prevention, earned that spot.

Source: ConsultantLive - June 4, 2018 Category: Internal Medicine Authors: Veronica Hackenthal, MD Tags: Headache and Migraine Source Type: news